Copper- and magnesium protoporphyrin complexes inhibit oxidative modification of LDL induced by hemin, transition metal ions and tyrosyl radicals

References

• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–924
   PubMed Web of Science ®Google Scholar
• Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488–2496
   PubMed Web of Science ®Google Scholar
• Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707–727
   PubMed Web of Science ®Google Scholar
• Steinberg D. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95: 1062–1071
   PubMed Web of Science ®Google Scholar
• Hazell LJ, Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 1993; 290(Pt 1)165–172
   PubMedGoogle Scholar
• Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun 1992; 17: 9–20
   PubMed Web of Science ®Google Scholar
• Chang GJ, Woo P, Honda HM, Ignarro LJ, Young L, Berliner JA, Demer LL. Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide. Dependence on pH and oxygen. Arterioscler Thromb 1994; 14: 1808–1814
   PubMedGoogle Scholar
• Wieland E, Parthasarathy S, Steinberg D. Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro: A model for in vivo oxidation?. Proc Natl Acad Sci USA 1993; 90: 5929–5933
   PubMed Web of Science ®Google Scholar
• Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J 1992; 288(Pt 2)341–344
   PubMedGoogle Scholar
• Witting PK, Upston JM, Stocker R. Role of alpha-tocopheroxyl radical in the initiation of lipid peroxidation in human low-density lipoprotein exposed to horse radish peroxidase. Biochemistry 1997; 36: 1251–1258
   PubMed Web of Science ®Google Scholar
• Singh RJ, Feix JB, Mchaourab HS, Hogg N, Kalyanaraman B. Spin-labeling study of the oxidative damage to low-density lipoprotein. Arch Biochem Biophys 1995; 320: 155–161
   PubMed Web of Science ®Google Scholar
• Santanam N, Parthasarathy S. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases. J Clin Investig 1995; 95: 2594–2600
   PubMed Web of Science ®Google Scholar
• Heinecke JW, Li W, Daehnke HL, III, Goldstein JA. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem 1993; 268: 4069–4077
   PubMed Web of Science ®Google Scholar
• Savenkova ML, Mueller DM, Heinecke JW. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem 1994; 269: 20394–20400
   PubMed Web of Science ®Google Scholar
• Heinecke JW. Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall. FASEB J 1999; 13: 1113–1120
   PubMed Web of Science ®Google Scholar
• Carr AC, McCall MR, Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: Reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 2000; 20: 1716–1723
   PubMed Web of Science ®Google Scholar
• Malle E, Waeg G, Schreiber R, Grone EF, Sattler W, Grone HJ. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: Colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem 2000; 267: 4495–4503
   PubMedGoogle Scholar
• Camejo G, Halberg C, Manschik-Lundin A, Hurt-Camejo E, Rosengren B, Olsson H, Hansson GI, Forsberg GB, Ylhen B. Hemin binding and oxidation of lipoproteins in serum: Mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res 1998; 39: 755–766
   PubMedGoogle Scholar
• Miller YI, Shaklai N. Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Biochim Biophys Acta 1999; 1454: 153–164
   PubMedGoogle Scholar
• Balla J, Balla G, Jeney V, Kakuk G, Jacob HS, Vercellotti GM. Ferriporphyrins and endothelium: A 2-edged sword-promotion of oxidation and induction of cytoprotectants. Blood 2000; 95: 3442–3450
   PubMed Web of Science ®Google Scholar
• Miller YI, Smith A, Morgan WT, Shaklai N. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. Biochemistry 1996; 35: 13112–13117
   PubMed Web of Science ®Google Scholar
• Miller YI, Felikman Y, Shaklai N. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation. Arch Biochem Biophys 1996; 326: 252–260
   PubMed Web of Science ®Google Scholar
• Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G. Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002; 100: 879–887
   PubMed Web of Science ®Google Scholar
• Bamm VV, Tsemakhovich VA, Shaklai N. Oxidation of low-density lipoprotein by hemoglobin-hemichrome. Int J Biochem Cell Biol 2003; 35: 349–358
   PubMedGoogle Scholar
• Ziouzenkova O, Asatryan L, Akmal M, Tetta C, Wratten ML, Loseto-Wich G, Jurgens G, Heinecke J, Sevanian A. Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis. J Biol Chem 1999; 274: 18916–18924
   PubMed Web of Science ®Google Scholar
• Miller YI, Felikman Y, Shaklai N. The involvement of low-density lipoprotein in hemin transport potentiates peroxidative damage. Biochim Biophys Acta 1995; 1272: 119–127
   PubMed Web of Science ®Google Scholar
• Boloor KK, Kamat JP, Devasagayam TP. Chlorophyllin as a protector of mitochondrial membranes against gamma-radiation and photosensitization. Toxicology 2000; 155: 63–71
   PubMed Web of Science ®Google Scholar
• Kamat JP, Boloor KK, Devasagayam TP. Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Biochim Biophys Acta 2000; 1487: 113–127
   PubMed Web of Science ®Google Scholar
• Hermann M, Gmeiner B. Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates. Arterioscler Thromb 1992; 12: 1503–1506
   PubMed Web of Science ®Google Scholar
• Dulley JR, Grieve PA. A simple technique for eliminating interference by detergents in the Lowry method of protein determination. Anal Biochem 1975; 64: 136–141
   PubMed Web of Science ®Google Scholar
• Kapiotis S, Besemer J, Bevec D, Valent P, Bettelheim P, Lechner K, Speiser W. Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood 1991; 78: 410–415
   PubMed Web of Science ®Google Scholar
• Kapiotis S, Hermann M, Held I, Seelos C, Ehringer H, Gmeiner BM. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 1997; 17: 2868–2874
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Exner M, Hermann M, Hofbauer R, Kapiotis S, Gmeiner BM. Free and peptide-bound DOPA can inhibit initiation of low density lipoprotein oxidation. Free Radic Res 2003; 37: 1147–1156
   PubMed Web of Science ®Google Scholar
• Exner M, Hermann M, Hofbauer R, Kapiotis S, Speiser W, Held I, Seelos C, Gmeiner BM. The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein. FEBS Lett 2000; 470: 47–50
   PubMed Web of Science ®Google Scholar
• Hermann M, Kapiotis S, Hofbauer R, Seelos C, Held I, Gmeiner B. Salicylate promotes myeloperoxidase-initiated LDL oxidation: Antagonization by its metabolite gentisic acid. Free Radic Biol Med 1999; 26: 1253–1260
   PubMed Web of Science ®Google Scholar
• Kapiotis S, Sengoelge G, Hermann M, Held I, Seelos C, Gmeiner BM. Paracetamol catalyzes myeloperoxidase-initiated lipid oxidation in LDL. Arterioscler Thromb Vasc Biol 1997; 17: 2855–2860
   PubMed Web of Science ®Google Scholar
• Bayse GS, Michaels AW, Morrison M. The peroxidase-catalyzed oxidation of tyrosine. Biochim Biophys Acta 1972; 284: 34–42
   PubMed Web of Science ®Google Scholar
• Kumar SS, Devasagayam TP, Bhushan B, Verma NC. Scavenging of reactive oxygen species by chlorophyllin: An ESR study. Free Radic Res 2001; 35: 563–574
   PubMed Web of Science ®Google Scholar
• Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Investig 1984; 74: 1890–1894
   PubMed Web of Science ®Google Scholar
• Drake TA, Hannani K, Fei HH, Lavi S, Berliner JA. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 1991; 138: 601–607
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341–390
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993; 49: 566–576
   PubMed Web of Science ®Google Scholar
• Halliwell B. The antioxidant paradox. Lancet 2000; 355: 1179–1180
   PubMed Web of Science ®Google Scholar
• Pietrzak M, Wieczorek Z, Stachelska A, Darzynkiewicz Z. Interactions of chlorophyllin with acridine orange, quinacrine mustard and doxorubicin analyzed by light absorption and fluorescence spectroscopy. Biophys Chem 2003; 104: 305–313
   PubMed Web of Science ®Google Scholar
• Egner PA, Munoz A, Kensler TW. Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res 2003; 523–524: 209–216
   PubMed Web of Science ®Google Scholar
• Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 2001; 98: 14601–14606
   PubMed Web of Science ®Google Scholar
• Dashwood RH. The importance of using pure chemicals in (anti) mutagenicity studies: Chlorophyllin as a case in point. Mutat Res 1997; 381: 283–286
   PubMed Web of Science ®Google Scholar
• Young RW, Beregi JS, Jr. Use of chlorophyllin in the care of geriatric patients. J Am Geriatr Soc 1980; 28: 46–47
   PubMed Web of Science ®Google Scholar
• Waters MD, Stack HF, Jackson MA, Brockman HE, De Flora S. Activity profiles of antimutagens: In vitro and in vivo data. Mutat Res 1996; 350: 109–129
   PubMed Web of Science ®Google Scholar
• Negishi T, Rai H, Hayatsu H. Antigenotoxic activity of natural chlorophylls. Mutat Res 1997; 376: 97–100
   PubMedGoogle Scholar
• Dashwood R, Negishi T, Hayatsu H, Breinholt V, Hendricks J, Bailey G. Chemopreventive properties of chlorophylls towards aflatoxin B1: A review of the antimutagenicity and anticarcinogenicity data in rainbow trout. Mutat Res 1998; 399: 245–253
   PubMed Web of Science ®Google Scholar
• Fruebis J, Bird DA, Pattison J, Palinski W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J Lipid Res 1997; 38: 2455–2464
   PubMed Web of Science ®Google Scholar
• Upston JM, Witting PK, Brown AJ, Stocker R, Keaney JF, Jr. Effect of vitamin E on aortic lipid oxidation and intimal proliferation after arterial injury in cholesterol-fed rabbits. Free Radic Biol Med 2001; 31: 1245–1253
   PubMedGoogle Scholar
• Upston JM, Terentis AC, Morris K, Keaney JF, Jr., Stocker R. Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis. Biochem J 2002; 363: 753–760
   PubMed Web of Science ®Google Scholar
• Vlad M, Bordas E, Caseanu E, Uza G, Creteanu E, Polinicenco C. Effect of cuprofilin on experimental atherosclerosis. Biol Trace Elem Res 1995; 48: 99–109
   PubMedGoogle Scholar